New York, New York 10001

  • Behavior, Health

Purpose:

The purpose of this study is to evaluate the preliminary efficacy of a Noom Breast Cancer Weight Loss Program on weight loss outcomes, quality of life, and physical activity. Also, to qualitatively determine acceptability of this novel program among breast cancer survivors with overweight or obesity.


Criteria:

Inclusion Criteria: - Able to understand and provide informed consent - 18 years and older - Overweight or obesity (BMI ≥ 27.5) - Not 6 months postpartum - Not planning to become pregnant in the next 7 months - Have a smartphone that is compatible with Noom's mobile app - Breast cancer survivor with stage I, II, or III - Completed active treatment (e.g, surgery, chemo, radiation, etc.) > 6 months ago Exclusion Criteria: - Inability or unwillingness of a participant to give written informed consent - Currently pregnant or < 6 months postpartum - Plans to become pregnant within the next 7 months - Stage IV, metastatic cancer or DCIS - Currently taking insulin - Uncontrolled hypertension


NCT ID:

NCT04753268


Primary Contact:

Christine May, PhD
Phone: (347) 687-8522
Email: christinem@noom.com


Backup Contact:

Email: siobhan@noom.com
Siobhan Mitchell, PhD
Phone: (347) 687-8522


Location Contact:

New York, New York 10001
United States

Ellen S MItchell, PhD
Phone: 347-687-8522
Email: Siobhan@noom.com

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: June 24, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.